EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population: Phenotypic Characterization

María Lourdes Garza-Rodríguez, Eren Adrián Alejandro Vargas-Márquez iD, Dione Aguilar, Samantha Trujillo-Bornios, Hugo Leonid Gallardo-Blanco iD, Oscar Vidal-Gutiérrez, Diana Cristina Pérez-Ibave, Carlos Horacio Burciaga-Flores iD

Genes · 2026

DOI: 10.3390/genes17050532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von María Lourdes Garza-Rodríguez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Oncología, Centro Universitario Contra el Cáncer (CUCC), Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nu…. Hauptthemen laut MEDLINE: Founder Effect, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oncology Service of CUCC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Germline CDKN2A variants are associated with Familial Atypical Mole-Malignant Melanoma (FAMMM) syndrome. This syndrome involves an increased risk of melanoma, pancreatic cancer, and, in specific populations, duodenal cancer, breast cancer, and astrocytoma. The CDKN2A (c.146T>C) variant has been found in hereditary cancer patients within the Mexican population. Furthermore, the phenotype linked to this variant in Mexico differs from that observed in other groups. This study aims to evaluate the founder effect of the CDKN2A (c.146T>C) variant through epidemiological analysis and to describe the phenotype within our population. Patients and Methods: We examined 72 Mexican patients (14 probands from distinct families, 48 relatives, and 10 nonrelated probands) carrying the CDKN2A (c.146T>C) form three hereditary cancer centers between September 2023 and September 2025.

Results

Of the 72 individuals analyzed, 52 (72.22%) tested positive. A cancer diagnosis was established in 27 (37.50%) of the individuals analyzed. Breast cancer was the most common neoplasia, accounting for 19 cases (70.37%), followed by melanoma with 4 cases (14.81%) and ovarian cancer with 2 cases (7.40%). Three patients (11.11%) had two distinct primary neoplasms.

Conclusions

Based on our findings and the fact that this variant has been reported nearly exclusively in the Mexican population, we conclude that it has a founder effect in this population. Additionally, the phenotype associated with this variant can vary among populations, with breast cancer being the most common carcinoma rather than melanoma among Mexican carriers, highlighting the importance of updating screening guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Founder EffectCyclin-Dependent Kinase Inhibitor p16HumansFemaleMexicoPhenotypeMaleMiddle AgedAdultGenetic Predisposition to DiseaseGerm-Line MutationMelanomaBreast NeoplasmsAgedPedigree

Stichwörter der Autor:innen

CDKN2Abreast cancerfounder effectgermline varianthereditary cancer

Substanzen

Cyclin-Dependent Kinase Inhibitor p16CDKN2A protein, human

Autor:innen und Institutionen

  • Servicio de Oncología, Centro Universitario Contra el Cáncer (CUCC), Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey 66451, Nuevo Leon, Mexico.
  • Laboratorio de Medicina de Conservación, Centro de Biotecnología Genómica, Instituto Politécnico Nacional (IPN), Reynosa 88710, Tamaulipas, Mexico.
  • Breast Cancer Center, Hospital Zambrano Hellion TecSalud, San Pedro Garza Garcia 66260, Nuevo Leon, Mexico.
  • Instituto Mexicano del Seguro Social (IMSS), Hospital de Ginecología y Obstetricia No. 23, Monterrey 64000, Nuevo Leon, Mexico.

ORCID-Profile: Eren Adrián Alejandro Vargas-Márquez, Hugo Leonid Gallardo-Blanco, Carlos Horacio Burciaga-Flores

Förderung

  • Oncology Service of CUCC

Zitieren

APA

Garza-Rodríguez, M. L., Vargas-Márquez, E. A. A., Aguilar, D., Trujillo-Bornios, S., Gallardo-Blanco, H. L., Vidal-Gutiérrez, O., Pérez-Ibave, D. C., & Burciaga-Flores, C. H. (2026). Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population: Phenotypic Characterization. Genes. https://doi.org/10.3390/genes17050532

Vancouver

Garza-Rodríguez ML, Vargas-Márquez EAA, Aguilar D, Trujillo-Bornios S, Gallardo-Blanco HL, Vidal-Gutiérrez O, et al. Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population: Phenotypic Characterization. Genes. 2026. doi:10.3390/genes17050532

BibTeX
@article{GarzaRodrguez2026,
  author = {Garza-Rodríguez, María Lourdes and Vargas-Márquez, Eren Adrián Alejandro and Aguilar, Dione and Trujillo-Bornios, Samantha and Gallardo-Blanco, Hugo Leonid and Vidal-Gutiérrez, Oscar and Pérez-Ibave, Diana Cristina and Burciaga-Flores, Carlos Horacio},
  title = {Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population: Phenotypic Characterization},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17050532}
}
Kostenlos starten →